RotaChrom Revenue and Competitors

Budapest,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • RotaChrom's estimated annual revenue is currently $8.4M per year.(i)
  • RotaChrom's estimated revenue per employee is $201,000

Employee Data

  • RotaChrom has 42 Employees.(i)
  • RotaChrom grew their employee count by -7% last year.

RotaChrom's People

NameTitleEmail/Phone
1
Regional Sales ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is RotaChrom?

RotaChrom Technologies is the inventor and first worldwide manufacturer of the Industrial Scale Centrifugal Partition Chromatography (iCPC) platforms. The company revolutionizes the pharmaceutical and cannabis industries by manufacturing and selling unique inventions of a special purifying technology. A cost-efficient and easily adaptable separation solution is offered for active pharmaceutical ingredients (API) and cannabinoids. The cost and the risk profile of R&D, as well as production can be significantly lower by using CPC tools, thereby pharmaceutical and cannabis-based products can become more widely available. Since its establishment, the company has achieved massive international success in pharmaceutical and pharma-graded cannabis purification. It has become an industry-leading company by setting global purification standards in the cannabis industry. RotaChrom's CPC platforms are quintessential applications when looking for a high-purity and high-capacity, yield-focused solution.

keywords:N/A

N/A

Total Funding

42

Number of Employees

$8.4M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M44N/AN/A
#2
$7.5M46-8%N/A
#3
$12.4M4820%N/A
#4
$5.8M48-13%N/A
#5
$7.3M566%N/A